Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Pembrolizumab 400 / Belzutifan 120, Renal Cell Carcinoma, adjuvant

Protocol-ID: 3245 V1.0 (Mini), PEMB400/BELZ120, RCC, adj.

Indication(s)

  • Renal Cell Carcinoma; ICD-10 C64
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician.

Valid since: 30.10.2026